Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,124Revenue $M71.2Net Margin (%)-44.8Z-Score1.7
Enterprise Value $M1,185EPS $-0.7Operating Margin %-44.9F-Score2
P/E(ttm))0Cash Flow Per Share $0.2Pre-tax Margin (%)-48.6Higher ROA y-yN
Price/Book7.010-y EBITDA Growth Rate %0Quick Ratio4.2Cash flow > EarningsY
Price/Sales10.45-y EBITDA Growth Rate %-53.9Current Ratio4.9Lower Leverage y-yN
Price/Cash Flow73.5y-y EBITDA Growth Rate %0ROA % (ttm)-15.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-34.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.3ROI % (ttm)-21.0Gross Margin Increase y-yN

Gurus Latest Trades with FLDM

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
FLDMPRIMECAP Management 2013-06-30 Add0.02%$16 - $19.04
($17.55)
$ 39.78127%Add 31.95%3,746,323
FLDMPRIMECAP Management 2013-03-31 Add0.04%$14.27 - $19.38
($16.88)
$ 39.78136%Add 113.65%2,839,232
FLDMPRIMECAP Management 2012-12-31 Add0.03%$13.63 - $17.02
($14.8)
$ 39.78169%Add 495.25%1,328,900
FLDMPRIMECAP Management 2012-09-30 Buy 0.01%$12.8 - $17.15
($14.79)
$ 39.78169%New holding, 223250 sh.223,250
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FLDM is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
FLDM PRIMECAP Management 2014-09-303,689,63213.060.1+1.05%
Premium Most recent portfolio changes are included for Premium Members only!


FLDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2015-01-15Sell3,000$34.2412.59view
Worthington Gajus VincentPRESIDENT & CEO 2015-01-02Sell6,000$33.3715.52view
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2014-12-15Sell3,000$27.241.73view
JONES EVAN/ FADirector 2014-12-12Sell8,352$27.4440.49view
JONES EVAN/ FADirector 2014-12-09Sell3,336$28.3436.03view
JOG VIKRAMCHIEF FINANCIAL OFFICER 2014-12-08Sell3,950$29.0732.61view
Worthington Gajus VincentPRESIDENT & CEO 2014-12-01Sell6,000$30.0328.37view
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2014-11-17Sell3,000$29.5230.59view
JONES EVAN/ FADirector 2014-11-12Sell5,000$29.5530.46view
JONES EVAN/ FADirector 2014-11-11Sell10,000$28.833.85view

Press Releases about FLDM :

Quarterly/Annual Reports about FLDM:

News about FLDM:

Articles On GuruFocus.com
No related article found.

More From Other Websites
Fluidigm to Announce Q4/Full Year 2014 Financial Results and Host Conference Call for Investors Jan 27 2015
Strength Seen in Fluidigm (FLDM): Stock Moves 9.8% Higher - Tale of the Tape Jan 21 2015
Street Talk: INTC, HD, MU, JKHY & FLDM Jan 20 2015
Fluidigm's Preliminary Q4 Revenues Up Y/Y, Outlook Positive - Analyst Blog Jan 14 2015
FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 13 2015
Fluidigm Announces Preliminary Fourth Quarter 2014 Revenue and Issues 2015 Revenue Guidance Jan 13 2015
Fluidigm to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015
New Single-Cell Whole Genome Sequencing Workflow Allows Discovery of Novel Cellular Heterogeneity Dec 29 2014
Making Single-Cell Biology Work Dec 17 2014
Making Single-Cell Biology Work Dec 17 2014
Cepheid Gets FDA Clearance for Xpert Flu/RSV XC Test Nov 25 2014
Fluidigm to Present at the Piper Jaffray 26th Annual Healthcare Conference Nov 24 2014
Fluidigm's (FLDM) New Workflow to Allow High Throughput Nov 19 2014
Fluidigm (FLDM) Now a Strong Buy on Key Product Releases Nov 18 2014
Fluidigm Announces New High Throughput Workflow for Single-Cell mRNA Sequencing Nov 18 2014
FLUIDIGM CORP Financials Nov 14 2014
Genome testing is now easy, fast and pretty Nov 14 2014
Fluidigm Ushers in a New Era of Customer Experience Nov 10 2014
10-Q for Fluidigm Corp. Nov 08 2014
FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report Nov 06 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK